Profit and Loss Results Results Snapshot
Figures in Cr
Consolidated - Profit And Loss Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
No of Months
12
12
12
12
12
12
Operating Income
835.00
752.00
554.00
555.00
611.00
453.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
52.00
43.00
32.00
35.00
48.00
41.00
Net Sales
782.00
709.00
522.00
519.00
563.00
411.00
Expenditure (Ex Depriciation)
Stock Adjustments
-64.00
-1.00
36.00
-112.00
26.00
-13.00
Raw Materials Consumed
501.00
425.00
299.00
387.00
313.00
259.00
Power & Fuel Cost
56.00
47.00
35.00
32.00
23.00
18.00
Employee Cost
80.00
64.00
53.00
51.00
41.00
39.00
Operating Expenses
29.00
26.00
17.00
22.00
16.00
14.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
13.00
4.00
3.00
3.00
5.00
3.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
2.00
2.00
2.00
2.00
2.00
2.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
643.00
592.00
467.00
405.00
442.00
332.00
Operating Profit (PBDIT) excl Other Income
138.00
116.00
54.00
114.00
121.00
79.00
Other Income
6.00
4.00
4.00
5.00
3.00
5.00
Operating Profit (PBDIT)
145.00
121.00
59.00
119.00
124.00
85.00
Interest
18.00
23.00
21.00
18.00
11.00
12.00
Profit before Depriciation and Tax
126.00
97.00
37.00
100.00
113.00
72.00
Depreciation
34.00
31.00
32.00
32.00
22.00
22.00
Profit Before Taxation & Exceptional Items
92.00
66.00
5.00
68.00
91.00
50.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
92.00
66.00
5.00
68.00
91.00
50.00
Provision for Tax
24.00
16.00
1.00
0.00
30.00
18.00
Profit After Tax
67.00
49.00
3.00
67.00
60.00
32.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
324.00
287.00
297.00
247.00
195.00
179.00
Profit Available for appropriations
394.00
337.00
290.00
309.00
257.00
210.00
Appropriations
394.00
337.00
290.00
309.00
257.00
210.00
Equity Dividend (%)
40.00%
40.00%
30.00%
30.00%
30.00%
25.00%
Earnings Per Share
8.16
5.89
-0.83
7.35
7.39
3.73
Profit And Loss Analysis Highlights
Net Sales
YoY Growth in year ended Mar 2025 is 10.36% vs 35.86% in Mar 2024
Operating Profit (PBDIT) excl Other Income
YoY Growth in year ended Mar 2025 is 19.18% vs 114.08% in Mar 2024
Interest
YoY Growth in year ended Mar 2025 is -20.96% vs 7.04% in Mar 2024
Profit After Tax
YoY Growth in year ended Mar 2025 is 36.99% vs 1,166.70% in Mar 2024
Compare Profit and Loss Results of SMS Pharma.
Figures in Cr
consolidated - Profit And Loss Results
Change(INR)
Change(%)
No of Months
12
12
Operating Income
835.00
1,784.00
-949.00
-53.20%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
52.00
0.00
52.00
0%
Net Sales
782.00
1,784.00
-1,002.00
-56.17%
Expenditure (Ex Depriciation)
Stock Adjustments
-64.00
19.00
-83.00
-436.84%
Raw Materials Consumed
501.00
805.00
-304.00
-37.76%
Power & Fuel Cost
56.00
170.00
-114.00
-67.06%
Employee Cost
80.00
246.00
-166.00
-67.48%
Operating Expenses
29.00
136.00
-107.00
-78.68%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
13.00
28.00
-15.00
-53.57%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
2.00
26.00
-24.00
-92.31%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
643.00
1,517.00
-874.00
-57.61%
Operating Profit (PBDIT) excl Other Income
138.00
267.00
-129.00
-48.31%
Other Income
6.00
2.00
4.00
200.00%
Operating Profit (PBDIT)
145.00
269.00
-124.00
-46.10%
Interest
18.00
56.00
-38.00
-67.86%
Profit before Depriciation and Tax
126.00
213.00
-87.00
-40.85%
Depreciation
34.00
117.00
-83.00
-70.94%
Profit Before Taxation & Exceptional Items
92.00
95.00
-3.00
-3.16%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
92.00
95.00
-3.00
-3.16%
Provision for Tax
24.00
25.00
-1.00
-4.00%
Profit After Tax
67.00
69.00
-2.00
-2.90%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
324.00
838.00
-514.00
-61.34%
Profit Available for appropriations
394.00
907.00
-513.00
-56.56%
Appropriations
394.00
907.00
-513.00
-56.56%
Equity Dividend (%)
40%
60%
-20.00
Earnings Per Share
8.16
5.64
2.52
44.68%
Profit And Loss - Net Sales
Net Sales 782.75 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 10.36% vs 35.86% in Mar 2024
Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 138.99 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 19.18% vs 114.08% in Mar 2024
Profit And Loss - Interest
Interest 18.54 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -20.96% vs 7.04% in Mar 2024
Profit And Loss - Profit After Tax
Profit After Tax 67.40 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 36.99% vs 1,166.70% in Mar 2024
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
